Kenox Pharmaceuticals Inc. (Kenox), a leading innovator in Orally Inhaled and Nasal Drug Products (OINDPs), has expanded its capabilities...
Malema™, part of PSG and Dover (NYSE: DOV) and a leading provider of flow meter technologies for use in industrial and semiconductor...
The implementation of EU GMP Annex 1 marks a transformative shift for the sterile filling industry. With new requirements emphasizing barrier technology and “first air” contamination control, pharmaceutical manufacturers face critical decisions in adapting their processes. Johannes Rauschnabel of Syntegon explores how equipment suppliers can play a pivotal role in facilitating compliance and seamless integration of these advanced standards.
Life Science Outsourcing, Inc., a leading contract manufacturer and value-added service provider to medical device and life science companies, announced today that it has acquired J-Pac Medical, a manufacturing, packaging and sterilization outsourcing partner to medical device and diagnostic companies.
Cadence, Inc., a leading contract manufacturer of medical and drug delivery devices and specialty commercial products, announced today that it has acquired Utitec, Inc., a manufacturer specializing in miniature, deep drawn medical device and commercial components. Utitec is headquartered in Watertown, Conn., with an additional medical facility located in Alajuela, Costa Rica.
Pharmaceutical Engineering® magazine is proud to announce the 2021 Roger F. Sherwood Article of the Year is “Medical Device UDI Components Management in the European Union”
The Pennsylvania Biotechnology Center partnership offers biotech residents flexible, plug & play lab and research...
ILC Doveror specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market.
Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide
SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.
The new Biomerics office will be equipped with multiple balloon-forming machines, state-of-the-art test equipment, and a cleanroom that is ISO 13485:2016 certified.